Treating human cancer with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, the expression of a number of oncogenic miRNAs via up regulation of its target gene, 3/April/2014, 22.53

Mechanistic insight into the treatment of diabetes: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of IGF-IR via up regulation of its target gene, 4/April/2014, 22.48
April 3, 2014
Insights into the treatment of renal fibrosis with ureteral obstruction: Tumor suppressor p53 suppresses the expression of α-smooth muscle actin (α-SMA) via up regulation of its target gene, 4/April/2014, 16.59
April 4, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Treating human cancer with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, inhibits the expression of a number of oncogenic miRNAs via up regulation of its target gene, 3/April/2014, 22.53,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

 

Comments are closed.